劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02595 劲方医药-B

午间休市 02-09 11:58:30

30.980

-0.440

-1.40%

最高32.560	最低30.780	成交量12.52万
今开31.520	昨收31.420	日振幅5.67%
总市值114.63亿	流通市值104.71亿	总股本3.70亿
成交额392.26万	换手率0.04%	流通股本3.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"劲方医药-B","latestPrice":30.98,"timestamp":1770609510615,"preClose":31.42,"halted":0,"volume":125200,"delay":0,"changeRate":-0.014003819223424611,"floatShares":338000000,"shares":370000000,"eps":-26.20482,"marketStatus":"午间休市","change":-0.44,"latestTime":"02-09 11:58:30","open":31.52,"high":32.56,"low":30.78,"amount":3922584,"amplitude":0.056652,"askPrice":30.98,"askSize":600,"bidPrice":30.92,"bidSize":1600,"shortable":0,"etf":0,"ttmEps":-2.744,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770613200000},"marketStatusCode":3,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":31.42,"openAndCloseTimeList":[[1770600600000,1770609600000],[1770613200000,1770624000000]],"volumeRatio":0.479376,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02595","defaultTab":"news","newsList":[{"id":"1185604739","title":"劲方医药科技（上海）（02595）更新2026年1月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1185604739","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185604739?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:08","pubTimestamp":1770282516,"startTime":"0","endTime":"0","summary":"劲方医药科技（上海）股份有限公司于2026年2月5日披露截至2026年1月31日的股份变动月报表。报告期内，公司股本结构未发生变化，整体维持稳定。公司本月已发行股本总计为338,029,020股H股以及32,337,610股未上市股份，两类股份面值均为每股人民币0.1。各类股份数量较上月底保持一致。截至本月底，公司确认其已满足香港联交所对于最低公众持股量的要求。公告称，公司将继续遵守香港联交所《上市规则》等相关法规，持续保持股本结构和合规运营的透明度。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2609327740","title":"交银国际：预计医药板块今年持续稳中向好 建议寻找被低估医药股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609327740","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609327740?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:54","pubTimestamp":1770281655,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，恒生医疗保健指数本周累跌3.3%，表现跑输大市，去年第四季至今内资通过港股通持有医药股的比例亦出现轻微下降，外资持仓则有所提升，部分加仓创新药械及受惠于需求复苏的龙头CXO企业。在今年医药业务拓展中，交银国际建议关注小核酸、长效制剂、invivo CAR-T、新一代ADC/XDC等差异化平台，以及自免、代谢、CNS等疾病领域，认为该板块稳中向好的趋势将于今年延续，但仍有可能出现短期波动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","BK1147","SG9999014674.SGD","BK1587","BK1191","BK1161","09939","BK1583","BK1141","00013","BK1515","159938","LU2488822045.USD","BK1574","03329","01530","02268","BK1593","BK1588","02595"],"gpt_icon":0},{"id":"2609969413","title":"劲方医药-B02月04日获主力加仓125.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609969413","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609969413?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192941,"startTime":"0","endTime":"0","summary":"02月04日, 劲方医药-B股价涨7.33%，报收32.78元，成交金额3446.5万元，换手率0.32%，振幅8.97%，量比1.83。劲方医药-B今日主力资金净流入125.0万元，上一交易日主力净流入93.2万元。该股近5个交易日上涨7.06%，主力资金累计净流入7.0万元；近20日主力资金累计净流入1799.0万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161912a6d1f143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204161912a6d1f143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","02595","BK1574","BK1161"],"gpt_icon":0},{"id":"2606205043","title":"劲方医药-B盘中异动 大幅上涨5.39%报30.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606205043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606205043?lang=zh_cn&edition=full","pubTime":"2026-01-27 10:37","pubTimestamp":1769481473,"startTime":"0","endTime":"0","summary":"2026年01月27日早盘10时37分，劲方医药-B股票出现异动，股价大幅上涨5.39%。截至发稿，该股报30.500港元/股，成交量41.26万股，换手率0.12%，振幅3.66%。资金方面，该股资金流入292.844万港元，流出62.9932万港元。劲方医药-B股票所在的药品行业中，整体跌幅为0.55%。其相关个股中，四环医药、兆科眼科-B、英硅智能涨幅较大，振幅较大的相关个股有四环医药、德琪医药-B、英硅智能，振幅分别为10.27%、8.05%、6.88%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127103753a6b0eb9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127103753a6b0eb9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1574","BK1161","02595"],"gpt_icon":0},{"id":"2606262291","title":"【券商聚焦】交银国际首予劲方医药(02595)买入评级 指其重点先行品种临床数据优势显著","url":"https://stock-news.laohu8.com/highlight/detail?id=2606262291","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606262291?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:34","pubTimestamp":1769391259,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，劲方医药 建立了一条包括 6 款临床阶段候选药物的药物管线，并拥有RAS 产品候选矩阵，涵盖 KRAS G12C/G12D、泛 RAS 等细分赛道，及非降解类分子胶、功能性抗体协同偶联物等新型分子机制，其中 GFH925已在中国内地获批上市，为同靶点首款国产。未来12个月重点关注GFH925纳入医保后的销售放量节奏以及RAS管线更多PoC/I期数据读出。首次覆盖，给予买入评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973905","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","09939","159938"],"gpt_icon":0},{"id":"2606293728","title":"劲方医药-B盘中异动 快速下挫6.76%报27.040港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606293728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606293728?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:30","pubTimestamp":1769391044,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘09时30分，劲方医药-B股票出现异动，股价快速跳水6.76%。截至发稿，该股报27.040港元/股，成交量4000股，换手率0.00%，振幅10.07%。资金方面，该股资金流入5992港元，流出8.9656万港元。劲方医药-B股票所在的药品行业中，整体涨幅为0.12%。其相关个股中，九源基因、山东新华制药股份、海普瑞涨幅较大，振幅较大的相关个股有劲方医药-B、英硅智能、德琪医药-B，振幅分别为10.07%、3.51%、3.09%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126093044953e4618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126093044953e4618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","BK1574","BK1515","02595"],"gpt_icon":0},{"id":"2605042948","title":"交银国际：首次覆盖劲方医药-B(02595)给予买入评级 目标价51港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605042948","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605042948?lang=zh_cn&edition=full","pubTime":"2026-01-23 14:16","pubTimestamp":1769148985,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，首次覆盖劲方医药-B，给予买入评级，目标价51港元。首予买入评级该行预计公司2025-27年收入分别达到1.09/0.85/1.18亿元人民币，主要来自GFH925中国内地销售带来的相关合作收入和GFH375的海外合作收入。基于DCF估值模型，该行得到公司目标价51港元，对应2.3倍收入达峰时的市销率及87%的潜在升幅。未来12个月重点关注GFH925纳入医保后的销售放量节奏以及RAS管线更多PoC/I期数据读出。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","159938","02595"],"gpt_icon":0},{"id":"2603466070","title":"劲方医药-B01月13日获主力加仓89.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603466070","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603466070?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:15","pubTimestamp":1768292151,"startTime":"0","endTime":"0","summary":"01月13日, 劲方医药-B股价涨0.51%，报收31.36元，成交金额3436.5万元，换手率0.33%，振幅6.03%，量比0.50。劲方医药-B今日主力资金净流入89.5万元，上一交易日主力净流入402.9万元。该股近5个交易日上涨42.16%，主力资金累计净流入282.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入21.8万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113162500a4bdf44f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113162500a4bdf44f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","02595","09939"],"gpt_icon":0},{"id":"2602100513","title":"劲方医药-B盘中异动 早盘快速拉升5.01%报33.980港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602100513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602100513?lang=zh_cn&edition=full","pubTime":"2026-01-12 09:45","pubTimestamp":1768182304,"startTime":"0","endTime":"0","summary":"2026年01月12日早盘09时45分，劲方医药-B股票出现波动，股价大幅上涨5.01%。截至发稿，该股报33.980港元/股，成交量32.66万股，换手率0.10%，振幅5.75%。资金方面，该股资金流入406.205万港元，流出633.25万港元。劲方医药-B股票所在的药品行业中，整体涨幅为0.43%。其相关个股中，英硅智能、劲方医药-B、中国同辐涨幅较大，振幅较大的相关个股有先声药业、英硅智能、凯莱英，振幅分别为14.16%、7.34%、6.80%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112094504a70f71a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112094504a70f71a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","02595","BK1515","BK1574"],"gpt_icon":0},{"id":"1168058667","title":"一周港股牛熊榜 | 开年医药股狂欢，劲方医药周涨45%；晶泰控股、英矽智能周升25%；融创中国、鸿腾精密下挫11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168058667","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168058667?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:22","pubTimestamp":1767950551,"startTime":"0","endTime":"0","summary":"总结全周， $恒生指数$ 跌106点或0.41%， $恒生科技指数$ 跌49点或0.86%；本周市值百亿以上、日均成交千万以上表现最好五只股票是 $劲方医药-B$ 、 $量化派$ 、 $荣昌生物$  、$晶泰控股$  、$英矽智能$ ；表现最差的五只股票是 $云知声$ 、 $融创中国$、  $鸿腾精密$  、$汇聚科技$  、$环球新材国际$ 。重点关注创新药产业链，景气度预计将持续向上。新年第一个完整周，英矽智能升25.07%。本公司亦已取得联交所批准换股股份上市及买卖。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06616","09678","02228","09995","03696","02685","06088","01729","01918","02595"],"gpt_icon":1},{"id":"1118334302","title":"劲方医药（02595）更新2025年12月股份变动月报，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1118334302","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118334302?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:36","pubTimestamp":1767774966,"startTime":"0","endTime":"0","summary":"劲方医药科技 (上海) 股份有限公司（02595.HK）于2026年1月7日披露2025年12月股份变动月报表。报告期内，公司已发行股本总额为人民币37,036,663元，其中上市H股338,029,020股，未上市股份32,337,610股，与上月底保持一致。\n根据月报信息，公司在2025年12月期间未有新增发行、购回、注销或库藏股活动，亦无股份期权或可换股债券等其他股权激励工具变动。截至报告期末，公司股本结构和数量保持稳定。\n公司在公告中确认已遵守香港联交所上市规则及相关法律规定。该报告由公司联席公司秘书张巍签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0},{"id":"2601275885","title":"劲方医药-B01月05日遭主力抛售42.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601275885","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601275885?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600955,"startTime":"0","endTime":"0","summary":"01月05日, 劲方医药-B股价跌6.00%，报收21.00元，成交金额4077.2万元，换手率0.56%，振幅11.37%，量比3.31。劲方医药-B今日主力资金净流出42.9万元，连续3日净流出，上一交易日主力净流出308.1万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为100.00%，平均跌幅为4.94%。该股近5个交易日下跌15.39%，主力资金累计净流出146.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入29.0万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162211a6f51444&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105162211a6f51444&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","09939","02595"],"gpt_icon":0},{"id":"2593177026","title":"劲方医药-B盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593177026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593177026?lang=zh_cn&edition=full","pubTime":"2025-12-22 10:09","pubTimestamp":1766369371,"startTime":"0","endTime":"0","summary":"2025年12月22日早盘10时09分，劲方医药-B股票出现波动，股价大幅跳水5.10%。截至发稿，该股报25.700港元/股，成交量11.96万股，换手率0.04%，振幅5.47%。劲方医药-B股票所在的药品行业中，整体涨幅为0.14%。其相关个股中，三爱健康集团、泰德医药、雅各臣科研制药涨幅较大，振幅较大的相关个股有君圣泰医药-B、九源基因、劲方医药-B，振幅分别为15.65%、5.82%、5.10%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222100931a4683b70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222100931a4683b70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","02595","09939"],"gpt_icon":0},{"id":"2592718602","title":"劲方医药-B12月18日主力净流出50.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592718602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592718602?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:16","pubTimestamp":1766045762,"startTime":"0","endTime":"0","summary":"12月18日, 劲方医药-B股价跌2.27%，报收26.74元，成交金额660.3万元，换手率0.07%，振幅2.56%，量比0.48。劲方医药-B今日主力资金净流出50.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌4.86%，主力资金累计净流出143.6万元；近20日主力资金累计净流入419.0万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162348a6b1a658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218162348a6b1a658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","09939","BK1515","BK1161","BK1574"],"gpt_icon":0},{"id":"2591068748","title":"劲方医药-B12月12日主力净流出93.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2591068748","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591068748?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:16","pubTimestamp":1765527364,"startTime":"0","endTime":"0","summary":"12月12日, 劲方医药-B股价跌0.70%，报收28.18元，成交金额2087.2万元，换手率0.22%，振幅4.86%，量比2.28。劲方医药-B今日主力资金净流出93.1万元，上一交易日主力净流入137.3万元。该股近5个交易日上涨1.29%，主力资金累计净流入187.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入293.0万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162917a4445eda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212162917a4445eda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2590599080","title":"开启最后“倒计时”，稳健横盘成劲方医药-B(02595)“入通”关键？","url":"https://stock-news.laohu8.com/highlight/detail?id=2590599080","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590599080?lang=zh_cn&edition=full","pubTime":"2025-12-11 17:26","pubTimestamp":1765445193,"startTime":"0","endTime":"0","summary":"除去3只标的将以“A+H”形式获纳入外，剩下28只则有望因满足“入通门槛”获纳入，劲方医药-B便是其中之一。上市以来稳健走势成“入通”关键目前数据显示，劲方医药在本次检讨周期内的日平均市值为102.96亿港元，较最新的92.42亿港元市值门槛高出超10亿港元。从劲方医药上市以来的表现来看，经历上市前期震荡下跌后实现止跌回稳的股价走势无疑是其“冲通”的关键因素。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","09939","BK1574","02595","BK1515","159938"],"gpt_icon":0},{"id":"2590546467","title":"劲方医药-B12月11日获主力加仓137.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590546467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590546467?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440950,"startTime":"0","endTime":"0","summary":"12月11日, 劲方医药-B股价涨2.09%，报收28.38元，成交金额1500.6万元，换手率0.16%，振幅3.67%，量比1.88。劲方医药-B今日主力资金净流入137.3万元，连续3日净流入，上一交易日主力净流入133.3万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为25.00%，平均涨幅为4.80%。该股近5个交易日下跌0.21%，主力资金累计净流入327.8万元；近20日主力资金累计净流入466.4万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162045a441f3c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162045a441f3c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1574","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"2589840925","title":"全球首个口服KRAS G12D抑制剂启动III期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2589840925","media":"医药地理","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589840925?lang=zh_cn&edition=full","pubTime":"2025-12-06 09:25","pubTimestamp":1764984347,"startTime":"0","endTime":"0","summary":"近日，劲方医药宣布其自主研发的口服KRAS G12D抑制剂GFH375治疗经治KRAS G12D突变型转移性胰腺癌患者的注册性III期试验已在北京大学肿瘤医院启动。此外，GFH375/VS-7375已获得FDA快速通道资格认定，治疗局部晚期及转移性KRAS G12D突变型PDAC患者。GFH375为口服高活性、高选择性小分子KRAS G12D抑制剂，通过非共价形式结合KRAS G12D蛋白，抑制其与下游效应蛋白结合，从而在细胞中破坏KRAS G12D对下游通路的持续活化，最终高效抑制肿瘤细胞增殖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206093732a43723e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206093732a43723e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02595"],"gpt_icon":0},{"id":"2589885635","title":"劲方医药-B(02595)：GFH375治疗转移性胰腺癌注册性临床试验在首家研究中心启动 为全球首个口服KRAS G12D抑制剂单药对照化疗III期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2589885635","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589885635?lang=zh_cn&edition=full","pubTime":"2025-12-05 08:16","pubTimestamp":1764893771,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B 发布公告，口服KRAS G12D 抑制剂GFH375治疗经治 KRAS G12D突变型转移性胰腺癌患者的注册性III期试验已在北京大学肿瘤医院启动。这项多中心、开放标签、随机对照的III期试验将在约40家中心开展，计划入组约320例既往接受至少一种标准系统性治疗的转移性胰腺癌患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","159938","III","BK1574","09939","BK1161","BK4134","02595"],"gpt_icon":0},{"id":"1149658391","title":"劲方医药（02595）更新2025年11月股份变动月报，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1149658391","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149658391?lang=zh_cn&edition=full","pubTime":"2025-12-04 18:11","pubTimestamp":1764843086,"startTime":"0","endTime":"0","summary":"劲方医药科技（上海）股份有限公司于2025年12月4日公布2025年11月股份变动月报。报告期覆盖2025年11月1日至11月30日。公司已发行H股338,029,020股，未上市股份32,337,610股，面值均为每股人民币0.1元。截至2025年11月30日，已发行股本总数为370,366,630股，对应注册（已发行）股本37,036,663元人民币。公司确认已遵守香港联合交易所有限公司《上市规则》及相关法律法规，报告中提及的股份变动事项均获得董事会正式授权并合规办理。公告由联席公司秘书张巍签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genfleet.com","stockEarnings":[{"period":"1week","weight":0.0235},{"period":"1month","weight":0.3235},{"period":"3month","weight":0.1637},{"period":"6month","weight":0.541},{"period":"ytd","weight":0.3213}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0121},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.2713},{"period":"ytd","weight":0.0363}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"劲方医药科技（上海）有限公司是一家专注于创新药物研发的中国公司。该公司为肿瘤、自身免疫性疾病和炎症性疾病提供有效的新型治疗方案。该公司的研发平台涵盖靶点发现、分子发现与评估、转化科学和临床开发，以及制剂研究、工艺开发和质量分析等关键化学生产和控制环节。该公司主要致力于新分子类型和新药物模式的开发，分子工艺路线和质量标准的研究，以及差异化临床开发策略和路径的探索。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"劲方医药-B","nameEN":"GENFLEET-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供劲方医药-B(02595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"劲方医药-B,02595,劲方医药-B股票,劲方医药-B股票老虎,劲方医药-B股票老虎国际,劲方医药-B行情,劲方医药-B股票行情,劲方医药-B股价,劲方医药-B股市,劲方医药-B股票价格,劲方医药-B股票交易,劲方医药-B股票购买,劲方医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"劲方医药-B(02595)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供劲方医药-B(02595)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}